[EN] PYRIMIDINONE CARBOXAMIDES AS INHIBITORS OF ENDOTHELIAL LIPASE<br/>[FR] PYRIMIDINONE CARBOXAMIDES EN TANT QU'INHIBITEURS D'UNE LIPASE ENDOTHÉLIALE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2013151923A1
公开(公告)日:2013-10-10
The present invention provides compounds of Formula (I): (I) as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicaments.
PYRIMIDINONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20150361052A1
公开(公告)日:2015-12-17
The present invention provides compounds of Formula (I): (I) as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicaments.
PYRIMIDINONE CARBOXAMIDES AS INHIBITORS OF ENDOTHELIAL LIPASE
申请人:Bristol-Myers Squibb Company
公开号:EP2847174A1
公开(公告)日:2015-03-18
US9394260B2
申请人:——
公开号:US9394260B2
公开(公告)日:2016-07-19
Substituted Tetrahydroimidazopyridine Compounds and the Use Thereof in the Treatment of Pain and Other Conditions
申请人:MERLA Beatrix
公开号:US20090186902A1
公开(公告)日:2009-07-23
Substituted tetrahydroimidazopyridine compounds corresponding to formula I:
in which R
1
, R
2
and R
3
have defined meanings, processes for preparing such compounds, pharmaceutical compositions containing such compounds, and the use of such compounds for treating or inhibiting pain, epilepsy, migraine, anxiety or urinary incontinence.